Tumour-based testing of BCCs in patients with LS was rarely undertaken, with 3 (9%) assessed by IHC; all of which were reported to demonstrate a consistent MMR protein loss (100%), and only one case (3%) was tested for MSI, and it was also found to be MSI (100%). The gene discussed is MRC1; the disease is neoplasm.